Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Richard G. Richards"'
Autor:
Tim Patterson, David A. Williams, James M. Miller, Catherine A. Insley, James M. Stuart, David J. Irwin, Philip Milner, Richard G. Richards
Publikováno v:
Journal of Public Health. 19:162-170
Between 8 December 1995 and 16 January 1996 seven laboratory confirmed cases of septicaemia owing to infection with Neisseria meningitidis serogroup C strains and one highly probable case of meningococcal septicaemia occurred in three electoral wards
Autor:
Richard G, Richards
Publikováno v:
BMJ (Clinical research ed.). 342
Autor:
Richard G, Richards
Publikováno v:
BMJ (Clinical research ed.). 341
Autor:
Richard G, Richards
Publikováno v:
BMJ (Clinical research ed.). 341
Autor:
Richard G Richards
EDITOR—Taylor's enthusiasm for the proposed “sale or return” arrangement for interferon beta seems ill informed.1 Given the variability of multiple sclerosis over time in individual patients, how is the success of treatment to be judged? Using
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfbedb1a87581ae346154210984b00bc
https://europepmc.org/articles/PMC1122918/
https://europepmc.org/articles/PMC1122918/
Autor:
Richard G Richards
Publikováno v:
BMJ. 342:d2285-d2285
How will the variations highlighted in the NHS Health Atlas of Variation in Healthcare be addressed,1 when little has changed since Glover’s analysis of the variation in tonsillectomy rates in England in 1938?2 Foundation trust contracts should req
Autor:
Richard G. Richards
Publikováno v:
Journal of Public Health. 32:590-590
Autor:
Richard G Richards
Publikováno v:
BMJ. 341:c4289-c4289
Davies does not deal with an important question about private finance initiative (PFI) contracts: Who are they with?1 It would be …
Autor:
Richard G Richards
Publikováno v:
BMJ. 341:c3589-c3589
With reference to the use of interferon beta in multiple sclerosis,1 Betaferon is already off patent, and there has been an unholy scramble to get access to production facilities.2 Extavia is not a generic or biosimilar drug but simply another brande
Autor:
Richard G Richards
Publikováno v:
BMJ. 336:1323.3-1324
The National Institute for Health and Clinical Excellence (NICE) has recommended that cardiovascular risk should be calculated by adding the risks of coronary heart disease and stroke derived from the Framingham study.1 This is an elementary epidemio